Fortis Group Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41 Hold
3
﹤0.01% 607
2026
Q1
$18 Hold
3
﹤0.01% 575
2025
Q4
$22 Hold
3
﹤0.01% 570
2025
Q3
$32 Hold
3
﹤0.01% 529
2025
Q2
$29 Hold
3
﹤0.01% 522
2025
Q1
$45 Hold
3
﹤0.01% 489
2024
Q4
$45 Hold
3
﹤0.01% 498
2024
Q3
$57 Hold
3
﹤0.01% 489
2024
Q2
$62 Hold
3
﹤0.01% 490
2024
Q1
$56 Sell
3
-3
-50% -$51 ﹤0.01% 502
2023
Q4
$86 Buy
6
+3
+100% +$41 ﹤0.01% 446
2023
Q3
$52 Buy
+3
New +$63 ﹤0.01% 441

Other funds holding OGN

Fortis Group Advisors's OGN Position: Q2 2026 in Review

Fortis Group Advisors held its Organon & Co (OGN) position steady in Q2 2026 at 3 shares worth $41. The position accounts for ﹤0.01% of the portfolio, ranked #607.

Fortis Group Advisors first reported a position in OGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $86 in Q4 2023. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Fortis Group Advisors held 3 shares of Organon & Co worth $41 as of Q2 2026.
  • Fortis Group Advisors left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Fortis Group Advisors's portfolio in Q2 2026, its #607 holding.
  • Fortis Group Advisors first reported a position in Organon & Co in Q3 2023 and has held it in 12 quarters since.
  • Fortis Group Advisors's Organon & Co position peaked at $86 in Q4 2023.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.